Form D · Pharmaceuticals
ARATANA THERAPEUTICS, INC.
Kansas City, KS · CIK 0001509190
Offering snapshot reported Oct 23, 2013 · SEC filing
- Reported sold
- $29.8M Offering amount: $29.8M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2013 | Initial | $29,750,000 | No comparison | 17 | SEC filing |
| Dec 28, 2012 | Initial | $0 | No comparison | 0 | SEC filing |
| Oct 25, 2011 | Initial | $0 | No comparison | 0 | SEC filing |
| Jan 7, 2011 | Initial | $10,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-205105
The offering involved (i) the issuance and sale of $19,750,000 of common shares in a private placement and (ii) the issuance of $10,000,000 of common shares in connection with an acquisition.
Source: Form D, filed Oct 23, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Rip Gerber | Director |
| Robert Gerber | Director |
| Ernst Heinen, D.V.M., Ph.D. | Executive |
| Jay Lichter | Director |
| Jay Lichter, Ph.D. | Director, Executive |
| Louise A. Mawhinney | Executive |
| Ronald L. Meeusen | Director |
| Ron Meeusen | Director |
| Ronald L. Meeusen, Ph.D. | Director |
| Linda Rhodes | Director, Executive |
| Linda Rhodes, V.M.D., Ph.D. | Director, Executive |
| David Rosen | Executive |
| Julia A. Stephanus | Executive |
| Steven St. Peter | Director, Executive |
| Steven St. Peter, M.D. | Director, Executive |
| Craig Tooman | Director |
| John Vander Vort | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1901 Olathe Boulevard
Kansas City, KS, 66103
Kansas City, KS, 66103